Study uses metabolomics to discriminate drug-induced liver injury phenotypes

By | December 30, 2021
Drug-induced liver injury (DILI) is an adverse reaction to ingesting a drug, which can appear both in developmental stages, in their clinical use and even after being approved as a drug.